Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Keiji Matsunami"'
Autor:
Shingo Matsumoto, Tomohiro Sakamoto, Kensaku Okada, Kazuhiro Hashimoto, Jun Kurai, Tadashi Igishi, Naoto Burioka, Eiji Shimizu, Masaki Nakamoto, Hiroki Chikumi, Keiji Matsunami, Masahiro Kodani, Tsuyoshi Kitaura, Miyako Takata, Akira Yamasaki
Publikováno v:
Oncology Reports
Mutations in the epidermal growth factor receptor (EGFR) gene are associated with a favorable clinical response to the EGFR tyrosine kinase inhibitors gefitinib and erlotinib in non-small cell lung cancer (NSCLC). We present here, a new method for th
Autor:
Hiromitsu Sakai, Hirokazu Touge, Akira Yamasaki, Katsuyuki Tomita, Keiji Matsunami, Eiji Shimizu
Publikováno v:
The American journal of hospicepalliative care. 35(4)
Few studies have examined variations in both the physical signs and clinical findings in the final days and hours before the death of elderly patients. We determined the physical signs and clinical findings in patients who were at least 75 years old
Autor:
Yasuto Ueda, Tsuyoshi Kitaura, Keiji Matsunami, Katsuyuki Tomita, Hiromitsu Sakai, Hirokazu Touge, Yuji Kawasaki, Eiji Shimizu, Akira Yamasaki, Shizuka Nishii
Publikováno v:
10.1 Respiratory Infections.
Aim: Frailty is at the core of geriatric syndromes that are characterized by multiple morbidities and mobility disability. The purpose of this prospective study was to assess the frailty scale and muscle mass on the acute phase in hospitalized elderl
Publikováno v:
Palliative Care Research. 7:185-191
Autor:
Yuji Kawasaki, Tsuyoshi Kitaura, Yasuto Ueda, Hiromitsu Sakai, Keiji Matsunami, Katsuyuki Tomita, Akira Yamasaki, Hirokazu Touge, Shizuka Nishii, Eiji Shimizu
Publikováno v:
Clinical Medicine Research. 6:86
Frailty is at the core of geriatric syndromes that are characterized by multiple morbidities and mobility limitations. The purpose of this case-control study was to assess the frailty scale and muscle mass on the acute phase in hospitalized elderly p
Autor:
Masahiro Kodani, Masato Morita, Tadashi Igishi, Hisashi Suyama, Yasuto Ueda, Kenichi Takeda, Keiji Matsunami, Hirofumi Nakazaki, Yasushi Shigeoka, Eiji Shimizu, Shingo Matsumoto, Takashi Sumikawa
Publikováno v:
Oncology Reports. 23
Small cell lung cancer (SCLC) is characterized by autocrine mechanisms. Stem cell factor (SCF) and its receptor c-kit can activate Akt and extracellular signal-regulated kinase (Erk) pathways. Imatinib mesylate (STI571) can inhibit c-kit tyrosine kin
Autor:
Miki, Yamamura, Kiyoshi, Hashimoto, Akira, Yamasaki, Yasuyuki, Hasegawa, Ryota, Okazaki, Hirofumi, Nakazaki, Keiji, Matsunami, Tatsuya, Hayabuchi, Toshiyuki, Tatsukawa, Hiroki, Chikumi, Tadashi, Igishi, Naoto, Burioka, Eiji, Shimizu
Publikováno v:
Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society. 47(4)
A 71-year-old woman was admitted to our hospital four times because of high fever and dyspnea from September to November in 2007. We treated her with antibiotics on her first two admissions. HOwever, we suspected hypersensitivity pneumonitis on the t
Autor:
Tadashi Igishi, Hiroki Chikumi, Tomohiro Sakamoto, Jun Kurai, Naomi Miyake, Hirokazu Touge, Masaki Nakamoto, Kosuke Yamaguchi, Keiji Matsunami, Eiji Shimizu, Masahiro Kotani, Shingo Matsumoto, Miyako Takata
Publikováno v:
Cancer Research. 73:LB-88
An epidermal growth factor receptor (EGFR) mutation is the best marker of sensitivity to the EGFR tyrosine kinase inhibitors gefitinib and erlotinib. Polymerase chain reaction (PCR)-based methods combined with the use of fluorescence probes, such as
Autor:
MIYAKO TAKATA, HIROKI CHIKUMI, KEIJI MATSUNAMI, MASAHIRO KODANI, TOMOHIRO SAKAMOTO, KAZUHIRO HASHIMOTO, MASAKI NAKAMOTO, KENSAKU OKADA, TSUYOSHI KITAURA, SHINGO MATSUMOTO, JUN KURAI, AKIRA YAMASAKI, TADASHI IGISHI, NAOTO BURIOKA, EIJI SHIMIZU
Publikováno v:
Oncology Reports; 2015, Vol. 33 Issue 3, p1040-1048, 9p